Teal Health has raised $10 million in a seed extension round led by Emerson Collective and Forerunner, boosting its total funding to $23 million. Founded in 2020 by Kara Egan and Dr. Avnesh Thakor, the company aims to revolutionize cervical cancer screenings by enabling women to conduct tests at home. The Teal Wand, pending FDA approval, will allow users to collect samples for telehealth consultations. Egan emphasized the importance of access to screenings, noting that many women are delayed in their preventive care. The funding will enhance Teal's telehealth platform and support expansion across the U.S.